Secondary non-traumatic avascular necrosis is a condition in which part of a bone loses its blood supply and starts to break down over time. It most often affects the hip, but it can also involve the knee, shoulder, or ankle, and many people first notice joint pain, stiffness, or a limp. The early symptoms of Secondary non-traumatic avascular necrosis can be mild at first, but the condition may worsen over months to years and can lead to joint collapse if it is not treated. It is seen more often in adults, especially people with certain risk factors such as long-term steroid use, heavy alcohol use, or some blood and autoimmune disorders; not everyone will have the same experience. Treatment often includes reducing weight on the joint, pain relief, physical therapy, and sometimes surgery such as procedures to protect the bone or replace the joint, and death from the condition itself is uncommon but overall health risks depend on the underlying cause.
How many people live with Secondary non-traumatic avascular necrosis?
A reliable worldwide estimate for how many people live with secondary non-traumatic avascular necrosis is not available, and the same is true for the United States. Most published reports give counts of new cases for the broader condition, avascular necrosis, rather than a direct count of people living with this specific form that is not caused by an injury.
Overview
Secondary non-traumatic avascular necrosisSymptoms
Secondary non-traumatic avascular necrosis often causes joint pain, stiffness, and a limp. Many people notice pain in the hip first, especially with walking or standing. Early symptoms of secondary non-traumatic avascular necrosis can be mild, then worsen as bone damage grows.
Outlook and prognosis
With secondary non-traumatic avascular necrosis, outlook depends on how early it is found, which joint is affected, and the cause. Early treatment may slow bone collapse and preserve movement. Advanced disease often leads to worsening pain, arthritis, and possible joint replacement.
Causes and risk factors
Secondary non-traumatic avascular necrosis is linked to reduced bone blood flow. Risk rises with long-term steroid use, heavy alcohol use, lupus, sickle cell disease, organ transplant, blood-clotting disorders, and sometimes smoking, high cholesterol, or prior radiation.
Genetic influences
Genetics may raise the risk of secondary non-traumatic avascular necrosis, but they are usually only part of the picture. In many living with secondary non-traumatic avascular necrosis, medicines, alcohol use, or other health conditions play a bigger role.
Diagnosis
Secondary non-traumatic avascular necrosis is usually diagnosed with a medical history, physical exam, and imaging, especially MRI. X-rays may be normal early on. The diagnosis of Secondary non-traumatic avascular necrosis may also include blood tests to look for an underlying cause.
Treatment and drugs
Treatment for Secondary non-traumatic avascular necrosis focuses on easing pain, protecting the joint, and slowing bone damage. Care may include treating the cause, limiting weight-bearing, physical therapy, medicines for pain, and sometimes surgery such as core decompression or joint replacement.
Symptoms
Walking, climbing stairs, or standing for long periods can become painful with secondary non-traumatic avascular necrosis, often before the joint looks any different from the outside. The early symptoms of secondary non-traumatic avascular necrosis can be easy to miss because discomfort may come and go at first. The hip is affected most often, but the knee, shoulder, and ankle can also be involved. As it progresses, pain, stiffness, and trouble moving the joint can make everyday tasks harder.
Some people with secondary non-traumatic avascular necrosis have no clear symptoms at first. When symptoms do appear, they often begin gradually rather than all at once.
Pain is usually felt deep inside the joint rather than on the surface. In the hip, it may show up in the groin, buttock, thigh, or even the knee; in other joints, it is usually centered where the damage is.
Walking, climbing stairs, or standing for a while can bring on pain or make it worse. What once felt effortless can start to require more energy or focus.
As secondary non-traumatic avascular necrosis gets worse, the joint may hurt even when you are sitting still or lying down. Night pain can disturb sleep and leave the joint feeling more sore by morning.
How people usually first notice Secondary non-traumatic avascular necrosis?
Secondary non-traumatic avascular necrosis often first shows up as a deep, persistent ache in a weight-bearing joint, most often the hip, and many people notice it when walking, climbing stairs, or standing for long periods starts to hurt for no clear reason. In the early stages, the pain may come and go and the joint can still look normal, which is why the first signs of secondary non-traumatic avascular necrosis are sometimes mistaken for a strain, arthritis, or overuse. As the problem progresses, the joint may become stiff, range of motion can shrink, and pain may start even at rest, which is usually when people realize something more serious may be going on.
Types of Secondary non-traumatic avascular necrosis
Secondary non-traumatic avascular necrosis is usually described by stage rather than by separate disease subtypes, because symptoms tend to change as the bone loses blood supply and becomes weaker. In practice, the main types of Secondary non-traumatic avascular necrosis are early-stage disease, pre-collapse disease, and advanced collapse with joint damage. Symptoms do not always look the same for everyone, and some people have very little pain at first while others notice steady worsening.
Early stage
Many people have no symptoms at first, or only mild deep aching in a hip, knee, shoulder, or other affected joint. Pain may show up mainly with walking, climbing stairs, or standing for a long time, then ease with rest. Range of motion is often still close to normal.
Pre-collapse stage
As the weakened area gets larger, pain often becomes more frequent and starts to interfere with everyday movement. Some may find the joint feels stiff, and weight-bearing can become harder even without a visible injury. A limp can begin if the hip or knee is involved.
Advanced collapse
Once the bone surface starts to flatten or the joint begins to wear down, pain is usually more constant and may be present even at rest or at night. Movement often becomes clearly limited, and daily tasks like getting out of a chair or walking short distances can be difficult. In later disease, symptoms can resemble arthritis in the affected joint.
Can I slow down the onset of symptoms?
Partly: research suggests you may be able to lower the chance of symptoms starting, or slow early worsening, by treating the underlying cause and reducing things that further harm blood flow to the bone, especially heavy alcohol use, smoking, and steroid use when a doctor says the dose can be safely lowered, along with keeping blood sugar, cholesterol, and overall heart and blood vessel health in a good range. This may reduce risk, but it does not prevent the condition for sure, and once the bone is already significantly damaged, lifestyle changes alone usually cannot stop symptoms from appearing. The most helpful medical step is early follow-up if you are at risk and prompt evaluation of new joint pain so treatment can begin early, which may help protect the joint for longer.
What genetics can tell you about symptoms
For people living with secondary non-traumatic avascular necrosis, genetics may help explain why some develop the condition earlier, in more than one joint, or with faster bone damage, especially when inherited traits affect blood clotting, red blood cells, fat handling, or how the body responds to steroids. Even so, genes do not reliably predict exactly which symptoms you will have, since pain, stiffness, limping, and loss of movement are also strongly shaped by the underlying cause, the joint involved, and how much bone has been affected. In short, genetics can sometimes point to higher risk or a different course, but they cannot by themselves forecast day-to-day symptoms or severity for most people.
Causes and risk factors
It often begins when blood flow to part of a bone drops because of another health problem or treatment. Common causes include long-term steroid use, heavy alcohol use, sickle cell disease, lupus, organ transplant, and some cancer treatments. Smoking, high cholesterol, blood-clotting disorders, radiation, and decompression exposure in divers can also raise the risk. Inherited traits can matter too, especially gene changes that increase clotting or conditions that affect red blood cells and blood flow. When doctors talk about risk factors for secondary non-traumatic avascular necrosis, they usually mean this mix of medical conditions, medicines, habits, and genetic susceptibility.
What are the most common causes or risk factors?
Secondary non-traumatic avascular necrosis most often happens when something reduces blood flow to part of a bone, especially long-term or high-dose steroid medicines such as prednisone and heavy alcohol use. Other well-known risk factors include sickle cell disease and some inherited blood-clotting problems, lupus and other long-term inflammatory illnesses, organ transplant, radiation treatment, and smoking. Not everyone with these risks develops it, but the chance is higher when several of them are present.
Environmental and biological risk factors
Secondary non-traumatic avascular necrosis develops when part of a bone loses enough blood supply without a major injury causing it. Some risks are carried inside the body, others come from the world around us. Knowing the risk factors for secondary non-traumatic avascular necrosis can help explain why doctors monitor some people more closely after certain illnesses or treatments. Often, more than one risk factor is present at the same time.
Long-term or high-dose steroid medicines, such as prednisone, are one of the strongest known risk factors. They can change fat handling and blood flow inside the bone, making secondary non-traumatic avascular necrosis more likely.
Conditions that make red blood cells stiff or misshapen, or that make blood clot too easily, can block the tiny vessels that feed bone. Over time, this reduced circulation can raise the risk of avascular necrosis.
Autoimmune illnesses such as lupus and conditions that inflame blood vessels can damage circulation to bone. Part of the risk also comes from the steroid treatment often needed for these diseases.
People who have had an organ transplant have a higher risk of secondary non-traumatic avascular necrosis. This is often linked to steroid exposure, immune-suppressing treatment, and changes in blood vessels or clotting after transplant.
Genetic risk factors
In secondary non-traumatic avascular necrosis, inherited conditions and gene changes can sometimes make bone more vulnerable when its blood supply drops. Some risk factors are inherited through our genes. The clearest genetic risk factors for secondary non-traumatic avascular necrosis are sickle cell disease, Gaucher disease, inherited clotting disorders, and rare family-linked gene changes that affect cartilage and bone. Many people with these risks never develop the condition, but knowing about them can help doctors take ongoing joint pain more seriously and look for problems earlier.
Sickle cell disease: In sickle cell disease, red blood cells can become stiff and block very small blood vessels. That can reduce blood flow to bone and greatly raise the risk of avascular necrosis, especially in the hip and shoulder.
Gaucher disease: Gaucher disease is an inherited condition that can affect the bone marrow and the circulation inside bones. People with Gaucher disease have a higher risk of bone injury and avascular necrosis over time.
Clotting disorders: Some inherited clotting tendencies make blood more likely to clot or less able to clear clots normally. Changes such as factor V Leiden, the prothrombin gene variant, or inherited deficiencies of protein C, protein S, or antithrombin have been linked to higher risk in some people.
COL2A1 changes: Rare inherited changes in the COL2A1 gene can run in families and increase the chance of osteonecrosis of the femoral head. These uncommon forms are more likely to be considered when several relatives have early hip disease without a clear trigger.
Family history: A strong family history of unexplained avascular necrosis can be a clue to an inherited risk, even when no single gene change has been identified yet. If early symptoms of secondary non-traumatic avascular necrosis appear in someone with affected relatives, doctors may think sooner about imaging and genetic evaluation.
Lifestyle risk factors
Several everyday habits can raise the chance that secondary non-traumatic avascular necrosis develops or gets worse, mainly by impairing blood flow to bone and increasing joint stress. The most important lifestyle-related factors are heavy alcohol use, smoking, low physical activity, excess body weight, and eating patterns that worsen cholesterol and triglyceride levels. When people ask about lifestyle risk factors for secondary non-traumatic avascular necrosis, these are the main modifiable issues clinicians usually review.
Long-term heavy drinking is one of the strongest lifestyle links to secondary non-traumatic avascular necrosis. It can disrupt fat metabolism, raise blood lipid levels, and contribute to reduced blood supply within bone.
Smoking damages blood vessels and reduces oxygen delivery to bone tissue. This may increase the risk of bone ischemia and can also slow recovery after symptoms begin or after surgery.
Diets that promote high cholesterol and high triglycerides may contribute to fatty deposits and impaired circulation in the small vessels that feed bone. Managing dietary fat quality and overall metabolic health may help lower this part of the risk.
Carrying excess body weight increases load across weight-bearing joints such as the hips and knees. In people with avascular necrosis, that added stress may worsen pain, speed joint collapse, and limit mobility.
Risk prevention
Secondary non-traumatic avascular necrosis happens when part of a bone loses enough blood supply and the bone tissue begins to break down, often in the hip, knee, or shoulder. In day-to-day life, this can mean deep joint pain when walking, climbing stairs, or even getting up from a chair. The condition cannot always be fully prevented, but many cases are linked to known risks that can sometimes be reduced. Prevention is about lowering risk, not eliminating it completely.
Long-term or high-dose steroid medicines are one of the most important preventable risks for secondary non-traumatic avascular necrosis. If you need steroids for another condition, ask whether the lowest effective dose or a different treatment could work just as well.
Heavy alcohol use raises the risk of fatty changes in the blood supply to bone and can contribute to secondary non-traumatic avascular necrosis. Cutting down or stopping alcohol may help protect the hip and other weight-bearing joints over time.
Smoking can narrow blood vessels and reduce oxygen delivery, which may make bone damage more likely. Stopping smoking supports circulation and may lower the risk of avascular necrosis and slower healing.
High cholesterol and high triglycerides can affect blood flow in small vessels that feed bone. Treating these problems with diet, exercise, and medicine when needed may lower risk, especially in people with other vascular risks.
Can you prevent Secondary non-traumatic avascular necrosis?
Not always. This kind of bone damage, caused by poor blood flow without an injury, cannot always be prevented, especially when it is linked to another health condition or to medicines you need. Still, risk may be lowered by avoiding heavy alcohol use, not smoking, and using steroid medicines only as prescribed and only when truly needed.
Transmission
Secondary non-traumatic avascular necrosis is not infectious, so it cannot be transferred from one person to another through close contact, coughing, sex, blood, food, or shared items. For many, this condition develops when blood flow to part of a bone drops over time, often linked to things like long-term steroid treatment, heavy alcohol use, or certain health conditions.
If you are wondering whether Secondary non-traumatic avascular necrosis is contagious, the answer is no. When people ask how Secondary non-traumatic avascular necrosis is inherited, the key point is that it is usually not passed directly from parent to child, although rare inherited traits can increase the risk in some families.
When to test your genes
For secondary non-traumatic avascular necrosis, genetic testing is not routine for early detection. It may be worth discussing if you developed osteonecrosis at a young age, have repeated or multifocal disease, or a strong family history, because inherited clotting or lipid disorders can sometimes shape evaluation and care.
Diagnosis
Pain in the hip, shoulder, knee, or another joint that slowly worsens with walking, climbing stairs, or standing for long periods is often what brings people in for care. In Secondary non-traumatic avascular necrosis, doctors usually piece the diagnosis together from your symptoms, risk factors, the joint exam, and imaging tests that show changes in the bone. Early and accurate diagnosis can help you plan ahead with confidence.
Doctors ask about when the pain started, what makes it worse, and whether you have stiffness, limping, or trouble with daily movement. They also look closely for common triggers such as steroid use, heavy alcohol use, lupus, blood disorders, organ transplant history, or prior radiation treatment.
A physical exam checks how well the joint moves and whether certain positions bring on pain. Many living with Secondary non-traumatic avascular necrosis have pain with weight-bearing or reduced range of motion, although early disease can be easy to miss on exam.
Plain X-rays are often the first imaging test because they are quick and widely available. They may look normal early on, but later they can show bone collapse, flattening of the joint surface, or changes linked to the diagnosis of Secondary non-traumatic avascular necrosis.
MRI is the most sensitive test for finding early bone damage before it appears on X-rays. Your provider may suggest MRI to look closer when symptoms strongly suggest avascular necrosis but initial imaging is unrevealing.
How is Secondary non-traumatic avascular necrosis diagnosed?
Doctors diagnose secondary non-traumatic avascular necrosis by putting together your symptoms, a physical exam, and imaging tests that look for bone damage caused by reduced blood flow. X-rays may show changes once the problem is more advanced, but an MRI scan is often the best way to find it early; a CT scan or bone scan is used less often. They also ask about things that can raise the risk, such as long-term steroid medicine, heavy alcohol use, or certain health conditions, and genetic testing is not usually part of diagnosis.
Stages of Secondary non-traumatic avascular necrosis
Secondary non-traumatic avascular necrosis usually does have recognized stages, based on how much the bone has been damaged and whether the joint surface has started to collapse. In the early phase, pain may come and go and X-rays can still look normal, so MRI is often the test that shows the problem sooner. The exact staging system can vary a little, but the overall pattern is similar across specialists. Early and accurate diagnosis helps you plan ahead with confidence.
Stage 1
Symptoms may begin with deep joint pain during walking, climbing stairs, or standing for a long time, even though standard X-rays may still look normal. Many people in this stage have what seem like early symptoms of secondary non-traumatic avascular necrosis, and MRI is often needed to confirm it.
Stage 2
The damaged area becomes easier to see on imaging, and pain often becomes more regular with daily activity. The bone is weakened, but the round shape of the joint surface is usually still preserved.
Stage 3
Small cracks can develop under the joint surface, and part of the bone may begin to collapse. Pain often worsens, stiffness can increase, and everyday movement may start to feel noticeably harder.
Stage 4
The joint surface becomes misshapen and arthritis-like wear develops in the joint. At this stage, pain may be present even at rest, and walking or using the affected joint can be quite limited.
Outlook and prognosis
The outlook for secondary non-traumatic avascular necrosis depends mainly on how early it is diagnosed, which joint is involved, how much bone has already collapsed, and whether the underlying cause, such as corticosteroid exposure, alcohol use, lupus, or sickle cell disease, can be controlled. In early-stage disease, treatment may slow progression and preserve the joint for years, but once structural collapse develops, pain and disability usually worsen and joint-preserving options become less effective. Many people eventually require joint replacement, especially when the hip is affected, although modern arthroplasty often provides substantial long-term pain relief and improved function. Mortality is not usually caused directly by the bone necrosis itself, but overall health outcomes can be influenced by the associated condition that led to it and by complications related to limited mobility. Prognosis is generally better with prompt imaging, reduced exposure to the triggering factor, and specialist follow-up before collapse occurs.
Long-term effects
Secondary non-traumatic avascular necrosis can have lasting effects because part of a bone loses its blood supply and may gradually weaken over time. In day-to-day life, this can mean pain with walking, climbing stairs, getting dressed, or standing for long periods, especially when the hip, knee, or shoulder is involved. Long-term effects vary widely, but the main concerns are worsening joint damage, loss of movement, and reduced independence if the bone collapses.
Pain often becomes the most noticeable long-term effect of secondary non-traumatic avascular necrosis. It may start with weight-bearing activity and later happen even at rest or during the night.
Stiffness and a smaller range of motion can make it harder to bend, reach, squat, or turn the joint smoothly. Many people notice small adjustments—like taking shorter steps or avoiding low chairs—long before the problem is severe.
If the weakened area can no longer support normal pressure, the surface of the bone may flatten or collapse. Once this happens, pain and disability usually increase, and joint damage often becomes harder to reverse.
Over time, the damaged bone can wear down the joint surface and lead to osteoarthritis. This is one reason early symptoms of avascular necrosis matter, since earlier treatment may help slow later joint destruction.
How is it to live with Secondary non-traumatic avascular necrosis?
Living with secondary non-traumatic avascular necrosis can feel like having a joint that gradually loses its strength from the inside out, often bringing deep pain, stiffness, and a limp that can make walking, climbing stairs, standing for long periods, or even sleeping more difficult. Many people find that daily life starts to revolve around pacing activity, avoiding high-impact movement, using a cane or other support, and planning around flares, medical visits, and sometimes surgery if the joint continues to collapse. This can also affect the people around you, because family, friends, and coworkers may need to help with errands, childcare, transportation, or physically demanding tasks, while also adjusting to the emotional strain that comes with living alongside chronic pain.
Treatment and drugs
Secondary non-traumatic avascular necrosis is treated by addressing both the bone damage and the underlying cause, such as long-term steroid use, heavy alcohol use, or another medical condition that is reducing blood flow to the bone. Early treatment may include limiting weight on the joint, physical therapy, pain relief, and sometimes medicines to support bone health, especially when early symptoms of secondary non-traumatic avascular necrosis are caught before the bone starts to collapse. Treatment plans often combine several approaches, and when damage is more advanced, doctors may recommend procedures to relieve pressure inside the bone, improve blood supply, reshape the joint, or replace the joint entirely. Not every treatment works the same way for every person, so care is usually tailored to which bone is affected, how far the condition has progressed, and what is driving it.
Can you cure Secondary non-traumatic avascular necrosis?
No, there is not a true cure for secondary non-traumatic avascular necrosis once part of the bone has been damaged from poor blood flow. Treatment can help ease pain, protect the joint, and sometimes slow or limit further damage, especially if it is found early and the underlying cause is treated. If the joint is badly affected, surgery, including joint replacement, may be needed to improve movement and daily life.
Non-drug treatment
Day to day, secondary non-traumatic avascular necrosis can make walking, climbing stairs, or even standing for long periods more painful as the affected bone loses its blood supply and weakens. Non-drug treatments often lay the foundation for relieving pain, protecting the joint, and helping people stay active for as long as possible. The best plan depends on which joint is affected, how much damage is already present, and whether the goal is to slow early symptoms of secondary non-traumatic avascular necrosis or treat later collapse and arthritis.
Cutting back on high-impact activity can reduce pressure on the damaged joint and may ease pain. Many living with secondary non-traumatic avascular necrosis do better with lower-impact movement, such as cycling, swimming, or water exercise.
Physical therapy can help maintain joint movement, improve muscle strength, and make daily tasks feel steadier. A therapist may also teach safer ways to walk, climb stairs, or move when the hip, knee, or shoulder is painful.
A cane, crutch, or walker can take weight off the affected side and help protect the joint. For many, treatment begins not at the pharmacy, but with simple support that makes walking less painful and lowers the risk of a limp getting worse.
If extra body weight is stressing a hip or knee, gradual weight loss can lessen joint load and improve comfort. Even small changes can lead to easier movement over time.
Your genes may have an impact on how drugs work for you
For people with secondary non-traumatic avascular necrosis, genetic differences can sometimes affect how the body handles medicines often used in care, especially pain relievers and, in some cases, steroid treatment linked to the condition in the first place. This can mean one person gets good pain relief with few side effects, while another may need a different dose or a different medicine because it does not work as well or causes problems. Even so, gene-based drug testing is not a routine part of treatment for this condition right now, and most care decisions are still based on symptoms, the cause of the bone damage, and how someone responds over time.
Pharmacological treatments
Secondary non-traumatic avascular necrosis is usually not treated with one single drug, because medicines cannot reliably bring dead bone back to life. Instead, treatment often focuses on easing pain and treating the cause that led to poor blood flow, such as long-term steroid use, clotting problems, or high blood fats. Medication can feel like a big step, but in this condition it is often just one part of care, alongside limiting joint stress and, in some cases, surgery. When people ask about medications for avascular necrosis of the hip or shoulder, the answer often depends on how early the disease is found and what is driving it.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen are often used to reduce pain and improve day-to-day movement. These medicines do not stop bone damage, but they can make walking, dressing, or sleep more manageable.
Drugs such as alendronate are sometimes used in early-stage avascular necrosis to try to slow bone collapse. The evidence is mixed, so they are not a standard answer for everyone with secondary non-traumatic avascular necrosis.
Statins such as atorvastatin or simvastatin may be used when high blood fats or steroid treatment are part of the picture. Their main role is to lower risk factors rather than directly repair the damaged bone.
Anticoagulants such as enoxaparin or warfarin may be considered if testing suggests a clotting tendency is contributing to reduced blood flow. These drugs are only used in selected people because they also raise the risk of bleeding.
Genetic influences
When blood flow to a bone is reduced without an injury, one of the first questions is often why it happened and whether family history mattered. In secondary non-traumatic avascular necrosis, genes usually do not act alone, but they can make some people more likely to develop bone damage after triggers such as steroid treatment, heavy alcohol use, or certain medical problems. It’s natural to ask whether family history plays a role. Inherited conditions that affect red blood cells or circulation, especially sickle cell disease, are well-known genetic causes of secondary non-traumatic avascular necrosis, and some rare clotting or metabolic disorders can raise the risk as well. Researchers have also found gene differences that may affect how the body handles steroids, fats, and blood clotting, which may help explain why one person develops secondary non-traumatic avascular necrosis while another does not under similar circumstances. Still, for many living with secondary non-traumatic avascular necrosis, genetics is only part of the picture, and genetic testing is usually considered only when an inherited disorder is suspected or the family history is strong.
Is Secondary non-traumatic avascular necrosis genetic?
Genetics may raise the risk of secondary non-traumatic avascular necrosis, but they are usually only part of the picture. In many living with secondary non-traumatic avascular necrosis, medicines, alcohol use, or other health conditions play a bigger role.
Having a genetic risk is not necessarily a diagnosis
Variants in genes are a common and normal part of human biology, and they are found across the general population. Most do not have a direct effect on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for secondary non-traumatic avascular necrosis is not usually guided by a single genetic test, so doctors do not yet have a standard pharmacogenetic panel that predicts the best drug for most people. Still, genes can matter in indirect ways: inherited conditions such as sickle cell disease can raise the risk of bone damage, and genetic differences may also affect how your body handles medicines linked to this problem, especially long-term corticosteroids. Genetics is only one factor; the cause of the bone damage, how far the condition has progressed, which joint is involved, and your overall health usually matter more when choosing pain relief, bone-protecting treatment, or surgery. For many living with secondary non-traumatic avascular necrosis, this means treatment is tailored more by symptoms and imaging than by DNA, especially when doctors are trying to protect the joint and preserve movement. If you’ve experienced side effects or lack of benefit, it is reasonable to ask whether any underlying inherited condition or medication response pattern could affect your care, but routine pharmacogenetic testing is not standard for secondary non-traumatic avascular necrosis at this time.
Interactions with other conditions
People living with secondary non-traumatic avascular necrosis often already have another health problem that affects blood flow, bone strength, or the way the body heals. It is commonly linked with conditions such as lupus, sickle cell disease, clotting disorders, and some autoimmune illnesses, and it may also appear after an organ transplant or alongside long-term kidney disease. Doctors call it a “comorbidity” when two conditions occur together. Day to day, this can mean hip or groin pain is harder to sort out, especially if fatigue, joint pain, or circulation problems from another illness are happening at the same time. Some treatments for other diseases, especially long-term high-dose steroid medicines, can raise the risk of secondary non-traumatic avascular necrosis or make it more likely to affect both sides of the body. Because the early symptoms of secondary non-traumatic avascular necrosis can overlap with arthritis, lupus flares, or pain from sickle cell disease, coordinated care can help doctors tell what is driving the symptoms and choose the safest treatment plan.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Secondary non-traumatic avascular necrosis?
Other problems that can look a lot like secondary non-traumatic avascular necrosis include osteoarthritis, stress fractures, and inflammation in or around the joint, such as bursitis or some forms of arthritis, because all can cause deep joint pain, stiffness, and trouble walking. In the hip, doctors may also need to rule out an infection in the joint or bone and, less often, a temporary bone swelling problem that can also cause sudden pain. Because the symptoms overlap so much, imaging tests such as X-rays or an MRI are often needed to tell them apart.
History
Long before scans could show damage inside a bone, doctors described people with deep joint pain, stiffness, and a limp that seemed to worsen over time without an obvious injury. What we now call secondary non-traumatic avascular necrosis was first recognized through these patterns, especially when the hip began to collapse even though there had been no major accident. For many, this could mean pain while walking to work, climbing stairs, or simply standing long enough to cook a meal.
Early understanding was limited because the condition can look like other causes of arthritis or bone damage in its first stages. Over time, as X-rays improved and later as MRI became available, doctors were able to see that the problem often starts when part of a bone loses enough blood supply and the bone tissue begins to die. This helped explain why early symptoms of secondary non-traumatic avascular necrosis can be easy to miss at first, then become more noticeable as the joint surface weakens.
Doctors also began to notice that this form of avascular necrosis was linked to certain medical situations rather than a fall or fracture. Reports gradually connected it with long-term steroid treatment, heavy alcohol use, some blood disorders, autoimmune disease, organ transplantation, and other health conditions that can affect blood flow or bone health. As medical science evolved, secondary non-traumatic avascular necrosis became easier to separate from traumatic forms caused by injury, which mattered because the risks, follow-up, and treatment planning were often different.
In recent decades, awareness has grown as imaging, surgery, and long-term patient follow-up have improved. Researchers have learned that not everyone follows the same course: some people are diagnosed early, before the bone shape changes, while others are only diagnosed after joint damage has already started. That growing understanding has shaped modern care, with more attention to spotting the condition sooner, looking for underlying causes, and trying to preserve the joint when possible.